Whole Brain Radiation Therapy Plus Stereotactic Radiosurgery in the Treatment of Brain Metastases Leading to Improved Survival in Patients With Favorable Prognostic Factors

Overview

Journal Front Oncol

Specialty Oncology

Date 2019 Apr 16

PMID 30984624

Citations 10

Authors

Muhammad Khan

Jie Lin

Guixiang Liao

Yunhong Tian

Yingying Liang

Rong Li

Mengzhong Liu

Yawei Yuan

Affiliations

Soon will be listed here.

Abstract

Significantly better local control is achieved with combination of whole brain radiotherapy and stereotactic radiosurgery in the treatment of multiple brain metastases. However, no survival benefit was reported from this advantage in local control. The objective of this study was to review the available evidence whether better local control achieved with whole brain radiotherapy plus stereotactic radiosurgery leads to any benefit in survival in patients with favorable prognostic factors. Electronic databases (PubMed, MEDLINE, and Cochrane Library) were searched until Oct 2018 to identify studies published in English that compared efficacy of whole brain radiotherapy plus stereotactic radiosurgery vs. whole brain radiotherapy alone or stereotactic radiosurgery alone in patients with brain metastases stratified on prognostic indices (Recursive Partitioning Analysis and Diagnosis-Specific Graded Prognostic Assessment). Primary outcome was survival. Five studies ( = 2728) were identified, 3 secondary analyses of the previously published RCTs and 2 retrospective studies, meeting the inclusion criteria. whole brain radiotherapy plus stereotactic radiosurgery showed improved survival in brain metastatic cancer patients with better prognostic factors particularly when compared to whole brain radiotherapy only. Its survival advantage over stereotactic radiosurgery only was limited to non-small cell lung cancer primary tumor histology. Whole brain radiotherapy in combination with stereotactic radiosurgery may improve survival and could be recommended selectively in patients with favorable prognostic factors particularly in comparison to whole brain radiotherapy only.

Citing Articles

Clinical advances in EGFR-TKI combination therapy for EGFR-mutated NSCLC: a narrative review.

Zhang Q, Wang R, Xu L Transl Cancer Res. 2024; 12(12):3764-3778.

PMID: 38192990 PMC: 10774042. DOI: 10.21037/tcr-23-956.

Patient reported outcomes following whole brain radiotherapy in patients with brain metastases in NSIA-LUTH Cancer Center.

Adegboyega B, Joseph A, Alabi A, Omomila J, Ngema L, Ainsworth V BMC Cancer. 2023; 23(1):1233.

PMID: 38098061 PMC: 10722749. DOI: 10.1186/s12885-023-11675-8.

Propensity score-matched analysis comparing hippocampus-avoidance whole-brain radiotherapy plus simultaneous integrated boost with hippocampus‑avoidance whole-brain radiotherapy alone for multiple brain metastases-a retrospective study in multiple....

Wang X, Chen J, Lei Z, Chen H, Zhang Y, Liu G BMC Cancer. 2023; 23(1):796.

PMID: 37620791 PMC: 10464036. DOI: 10.1186/s12885-023-11286-3.

Radiation Plus Anti-PD-1 Therapy for NSCLC Brain Metastases: A Retrospective Study.

Liao G, Qian Y, Arooj S, Zhao Z, Yan M, Li Z Front Oncol. 2021; 11:742971.

PMID: 34745964 PMC: 8567143. DOI: 10.3389/fonc.2021.742971.

Bevacizumab for radiation necrosis following radiotherapy of brain metastatic disease: a systematic review & meta-analysis.

Khan M, Zhao Z, Arooj S, Liao G BMC Cancer. 2021; 21(1):167.

PMID: 33593308 PMC: 7885379. DOI: 10.1186/s12885-021-07889-3.

References

Sneed P, Lamborn K, Forstner J, McDermott M, Chang S, Park E . Radiosurgery for brain metastases: is whole brain radiotherapy necessary?. Int J Radiat Oncol Biol Phys. 1999; 43(3):549-58. DOI: 10.1016/s0360-3016(98)00447-7. View

Lagerwaard F, Levendag P, Nowak P, Eijkenboom W, Hanssens P, Schmitz P . Identification of prognostic factors in patients with brain metastases: a review of 1292 patients. Int J Radiat Oncol Biol Phys. 1999; 43(4):795-803. DOI: 10.1016/s0360-3016(98)00442-8. View

Kondziolka D, Patel A, Lunsford L, Kassam A, Flickinger J . Stereotactic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases. Int J Radiat Oncol Biol Phys. 1999; 45(2):427-34. DOI: 10.1016/s0360-3016(99)00198-4. View

Weltman E, Salvajoli J, Brandt R, de Morais Hanriot R, Prisco F, Cruz J . Radiosurgery for brain metastases: a score index for predicting prognosis. Int J Radiat Oncol Biol Phys. 2000; 46(5):1155-61. DOI: 10.1016/s0360-3016(99)00549-0. View

Li B, Yu J, Suntharalingam M, Kennedy A, Amin P, Chen Z . Comparison of three treatment options for single brain metastasis from lung cancer. Int J Cancer. 2000; 90(1):37-45. View

Hoffman R, Sneed P, McDermott M, Chang S, Lamborn K, Park E . Radiosurgery for brain metastases from primary lung carcinoma. Cancer J. 2001; 7(2):121-31. View

Sanghavi S, Miranpuri S, Chappell R, Buatti J, Sneed P, Suh J . Radiosurgery for patients with brain metastases: a multi-institutional analysis, stratified by the RTOG recursive partitioning analysis method. Int J Radiat Oncol Biol Phys. 2001; 51(2):426-34. DOI: 10.1016/s0360-3016(01)01622-4. View

Wen P, Loeffler J . Brain metastases. Curr Treat Options Oncol. 2002; 1(5):447-58. DOI: 10.1007/s11864-000-0072-3. View

Sneed P, Suh J, Goetsch S, Sanghavi S, Chappell R, Buatti J . A multi-institutional review of radiosurgery alone vs. radiosurgery with whole brain radiotherapy as the initial management of brain metastases. Int J Radiat Oncol Biol Phys. 2002; 53(3):519-26. DOI: 10.1016/s0360-3016(02)02770-0. View

10.

Soffietti R, Ruda R, Mutani R . Management of brain metastases. J Neurol. 2002; 249(10):1357-69. DOI: 10.1007/s00415-002-0870-6. View

11.

Wang L, Guo Y, Zhang X, Song S, Xia J, Fan F . Brain metastasis: experience of the Xi-Jing hospital. Stereotact Funct Neurosurg. 2003; 78(2):70-83. DOI: 10.1159/000068015. View

12.

Noel G, Medioni J, Valery C, Boisserie G, Simon J, Cornu P . Three irradiation treatment options including radiosurgery for brain metastases from primary lung cancer. Lung Cancer. 2003; 41(3):333-43. DOI: 10.1016/s0169-5002(03)00236-8. View

13.

Andrews D, Scott C, Sperduto P, Flanders A, Gaspar L, Schell M . Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet. 2004; 363(9422):1665-72. DOI: 10.1016/S0140-6736(04)16250-8. View

14.

Lorenzoni J, Devriendt D, Massager N, David P, Ruiz S, Vanderlinden B . Radiosurgery for treatment of brain metastases: estimation of patient eligibility using three stratification systems. Int J Radiat Oncol Biol Phys. 2004; 60(1):218-24. DOI: 10.1016/j.ijrobp.2004.02.017. View

15.

Aoyama H, Shirato H, Tago M, Nakagawa K, Toyoda T, Hatano K . Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. JAMA. 2006; 295(21):2483-91. DOI: 10.1001/jama.295.21.2483. View

16.

Sperduto P, Berkey B, Gaspar L, Mehta M, Curran W . A new prognostic index and comparison to three other indices for patients with brain metastases: an analysis of 1,960 patients in the RTOG database. Int J Radiat Oncol Biol Phys. 2007; 70(2):510-4. DOI: 10.1016/j.ijrobp.2007.06.074. View

17.

Rades D, Dunst J, Schild S . A new scoring system to predicting the survival of patients treated with whole-brain radiotherapy for brain metastases. Strahlenther Onkol. 2008; 184(5):251-5. DOI: 10.1007/s00066-008-1831-5. View

18.

Golden D, Lamborn K, McDermott M, Kunwar S, Wara W, Nakamura J . Prognostic factors and grading systems for overall survival in patients treated with radiosurgery for brain metastases: variation by primary site. J Neurosurg. 2009; 109 Suppl:77-86. DOI: 10.3171/JNS/2008/109/12/S13. View

19.

Sperduto P, Chao S, Sneed P, Luo X, Suh J, Roberge D . Diagnosis-specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastases: a multi-institutional analysis of 4,259 patients. Int J Radiat Oncol Biol Phys. 2009; 77(3):655-61. DOI: 10.1016/j.ijrobp.2009.08.025. View

20.

Rades D, Dziggel L, Haatanen T, Veninga T, Lohynska R, Dunst J . Scoring systems to estimate intracerebral control and survival rates of patients irradiated for brain metastases. Int J Radiat Oncol Biol Phys. 2010; 80(4):1122-7. DOI: 10.1016/j.ijrobp.2010.03.031. View